An Investigation into the Quality of Medicines in Yangon, Myanmar
Many poor-quality medicines are supplied to patients mainly in developing countries. No systematic survey on counterfeit medicines has been conducted in Myanmar since 1999. The purpose of this study was to investigate the current situation of substandard or counterfeit medicines in Myanmar. Samples...
Main Authors: | Md. Rafiqul Islam, Naoko Yoshida, Kazuko Kimura, Chisana Uwatoko, Mohammad Sofiqur Rahman, Shoma Kumada, Jamie Endo, Kana Ito, Tsuyoshi Tanimoto, Theingi Zin, Hirohito Tsuboi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-08-01
|
Series: | Pharmacy |
Subjects: | |
Online Access: | http://www.mdpi.com/2226-4787/6/3/96 |
Similar Items
-
Substandard and Falsified Medicines in Myanmar
by: Mirai Sakuda, et al.
Published: (2020-03-01) -
Patient safety and public health concerns: poor dissolution rate of pioglitazone tablets obtained from China, Myanmar and internet sites
by: Mohammad Sofiqur Rahman, et al.
Published: (2021-03-01) -
A systematic review of counterfeit and substandard medicines in field quality surveys
by: Alghannam AFA, et al.
Published: (2014-09-01) -
Are we doing enough to prevent poor-quality antimalarial medicines in the developing world?
by: Erin J. Walker, et al.
Published: (2018-05-01) -
Erroneous formulation of delayed-release omeprazole capsules: alert for importing countries
by: Mohammad Sofiqur Rahman, et al.
Published: (2017-05-01)